Medtronic enrolled the SMART study in around 12 months (800 patients) so I see no reason why we couldn’t do the same.
- Forums
- ASX - By Stock
- Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
Medtronic enrolled the SMART study in around 12 months (800...
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$21.00 |
Change
0.000(0.00%) |
Mkt cap ! $403.4M |
Open | High | Low | Value | Volume |
$20.80 | $21.00 | $20.80 | $30.15K | 1.442K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 194 | $21.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.20 | 923 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 194 | 21.010 |
1 | 100 | 21.000 |
2 | 799 | 20.940 |
1 | 22 | 20.930 |
1 | 150 | 20.900 |
Price($) | Vol. | No. |
---|---|---|
21.200 | 923 | 2 |
21.700 | 421 | 1 |
22.790 | 289 | 1 |
22.800 | 200 | 1 |
22.900 | 250 | 1 |
Last trade - 10.15am 08/05/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online